single invest

The Cardiosynchrogram

The Cardiosynchrogram

The Cardiosynchrogram provides technology which can improve patient selection and treatment for a specific type of heart failure – an area where currently up to 40% of recipients do not benefit from treatment. The technology is an algorithm that analyzes standard clinical 12-lead ECG recordings and measures and visualizes (dys)synchrony in the electrical activation of the heart chambers.

The Cardiosynchrogram has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. The Cardiosynchrogram is one of more than 500 companies that Accelerace already have accelerated.


Related startups